Wachtell Guides AbbVie In $16.7B Bond Offering
Abbvie Inc., led by Wachtell Lipton Rosen & Katz, priced a $16.7 billion bond offering late Tuesday to help fund its $21 billion bid for cancer-drug maker Pharmacyclics Inc., making the...To view the full article, register now.
Already a subscriber? Click here to view full article